FIELD: medicine.
SUBSTANCE: disclosed is use of tradipitant for treating an individual suffering from atopic dermatitis or itching associated with atopic dermatitis, comprising administering to an individual tradipitant in dose of 170 mg/day by administering 85 mg twice a day, wherein the dose and frequency are sufficient to achieve and maintain a plasma concentration of tradipitant of 175 ng/ml or more during said treatment. Group of inventions also relates to the use of a tradipitant for preparing a drug for treating an individual suffering from atopic dermatitis or related itching.
EFFECT: provides effective treatment of atopic dermatitis and associated itching.
14 cl, 2 dwg, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATMENT WITH TRADIPITANT | 2016 |
|
RU2810253C2 |
| IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT | 2018 |
|
RU2812890C2 |
| IMPROVED TREATMENT OF ATOPIC DERMATITIS WITH TRADIPITANT | 2018 |
|
RU2793237C2 |
| METHOD FOR TREATMENT OF GASTROINTESTINAL TRACT DISEASES WITH TRADIPITANT | 2018 |
|
RU2797248C2 |
| TREATING ATOPIC DERMATITIS WITH TRADIPITANT | 2021 |
|
RU2818164C1 |
| PHARMACEUTICAL COMPOSITIONS CONTAINING DGLA, AND USE THEREOF | 2015 |
|
RU2714323C2 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS INCLUDING IL-31 ANTAGONIST AS AN ACTIVE INGREDIENT | 2016 |
|
RU2806304C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTION AND/OR TREATMENT OF ATOPIC DERMATITIS, INCLUDING IL-31 ANTAGONIST AS THE ACTIVE INGREDIENT | 2016 |
|
RU2749512C2 |
| METHODS OF TREATING ATOPIC DERMATITIS WITH THE HELP OF IL-4R ANTAGONIST | 2013 |
|
RU2698907C2 |
| METHODS FOR TREATING ATOPIC DERMATITIS BY ADMINISTERING IL-4R ANTAGONIST | 2013 |
|
RU2666630C2 |
